tirzepatide formulary Impact of the CVS GLP-1 change: Trends in switching Drug formulary hi-res stock photography

Currently, weight loss drugs like Wegovy (semaglutide) and Zepbound (tirzepatide) are very popular

Some tissues that might be particularly responsive to this signaling include muscle and bone cells

IV Solutions and IV Systems Hospira IV solutions include normal saline, dextrose solutions, lactated Ringer's, and specialty electrolyte blends in multiple bag sizes

Notably, semaglutide treatment led to a reduction in heart weight, left ventricular mass, and wall thickness, indicating a reduction in cardiac hypertrophy ( Figure 1C )

Current FDA-Approved Weight Loss Medications: GLP-1 and Dual Agonists (Most Effective): Tirzepatide (Zepbound) Approval: November 2023 Mechanism: Dual GIP/GLP-1 receptor agonist Average Weight Loss: 15-22% of body weight Administration: Weekly injection Semaglutide (Wegovy) Approval: June 2021 Mechanism: GLP-1 receptor agonist Average Weight Loss: 10-15% of body weight Administration: Weekly injection Liraglutide (Saxenda) Approval: December 2014 Mechanism: GLP-1 receptor agonist Average Weight Loss: 5-8% of body weight Administration: Daily injection Older Weight Loss Medications (Less Effective): Phentermine-Topiramate (Qsymia) Approval: July 2012 Mechanism: Appetite suppressant + anticonvulsant Average Weight Loss: 7-9% of body weight Administration: Daily pill Naltrexone-Bupropion (Contrave) Approval: September 2014 Mechanism: Opioid antagonist + antidepressant Average Weight Loss: 4-5% of body weight Administration: Daily pill Orlistat (Xenical, Alli) Approval: April 1999 (prescription), 2007 (OTC) Mechanism: Lipase inhibitor (blocks fat absorption) Average Weight Loss: 3-5% of body weight Administration: Three times daily with meals Phentermine (Adipex-P, Lomaira) Approval: 1959 Mechanism: Appetite suppressant Average Weight Loss: 5-7% of body weight Administration: Daily pill Restriction: Short-term use only (12 weeks) Effectiveness Ranking: Why GLP-1 Medications Dominate: The top three most effective medications are all GLP-1 receptor agonists